Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
McMaster University
$27,000.00
Exploring the role of SAM pointed domain containing Ets transcription factor (SPDEF) in the pathogenesis of colitis
FY 2025-26
Summary
Inflammatory Bowel Disease (IBD) causes chronic inflammation and damage to the digestive system. Changes to the protective mucus barrier of the digestive tract and changes in the bacteria living in the gut, called the gut microbiome, contribute to the disease. Mucus is made by goblet cells, a specialized cell in the digestive tract. IBD patients have less goblet cells and produce less mucus. As such, their digestive tract is less protected and harmful substances can attack the gut. Learning more about these mucus-producing cells is critical for a better understanding of what happens to the mucus barrier in IBD patients and how these changes contribute to the disease.
This project focuses on a gene called SPDEF, which is critical for goblet cell development and, thus, mucus production. If goblet cells do not develop properly, the mucus barrier may not form properly. Our lab has found that mice lacking SPDEF have fewer and less developed goblet cells in the large intestine and also produce less mucus, similar to what is seen in IBD patients. These mice also develop more severe colitis symptoms, suggesting that SPDEF is critical in maintaining a healthy intestinal mucus barrier.
The aim of this project is to understand the differences between mice lacking SPDEF and normal mice to investigate how the loss of this gene affects mucus production, immune reactions, and the gut microbiome and how this gene contributes to overall gut health. We will also investigate whether transferring gut microbes from SPDEF-deficient mice to healthy mice increases their risk of developing IBD-like inflammation. This project will allow us to understand the mechanisms underlying mucus barrier alterations in IBD, as well as assess potential treatment strategies for patients with this condition.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572812
Name
Kermanchi Kimia
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the role of SAM pointed domain containing Ets transcription factor (SPDEF) in the pathogenesis of colitis
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Goblet Cells; Gut Microbiota; Inflammatory Bowel Disease; Intestinal Epithelial Barrier; Intestinal Mucus Barrier; Microbiota Transfer; Mucins; Probiotics; Sam Point Domain-Containing Ets Transcription Factor; Spontaneous Colitis
Abstract
Inflammatory Bowel Disease (IBD) causes chronic inflammation and damage to the digestive system. Changes to the protective mucus barrier of the digestive tract and changes in the bacteria living in the gut, called the gut microbiome, contribute to the disease. Mucus is made by goblet cells, a specialized cell in the digestive tract. IBD patients have less goblet cells and produce less mucus. As such, their digestive tract is less protected and harmful substances can attack the gut. Learning more about these mucus-producing cells is critical for a better understanding of what happens to the mucus barrier in IBD patients and how these changes contribute to the disease.
This project focuses on a gene called SPDEF, which is critical for goblet cell development and, thus, mucus production. If goblet cells do not develop properly, the mucus barrier may not form properly. Our lab has found that mice lacking SPDEF have fewer and less developed goblet cells in the large intestine and also produce less mucus, similar to what is seen in IBD patients. These mice also develop more severe colitis symptoms, suggesting that SPDEF is critical in maintaining a healthy intestinal mucus barrier.
The aim of this project is to understand the differences between mice lacking SPDEF and normal mice to investigate how the loss of this gene affects mucus production, immune reactions, and the gut microbiome and how this gene contributes to overall gut health. We will also investigate whether transferring gut microbes from SPDEF-deficient mice to healthy mice increases their risk of developing IBD-like inflammation. This project will allow us to understand the mechanisms underlying mucus barrier alterations in IBD, as well as assess potential treatment strategies for patients with this condition.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kermanchi, Kimia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~